CEL Historical Financial Ratios

CVM Stock  USD 0.66  0.05  8.20%   
CEL SCI is presently reporting on over 106 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0025, PTB Ratio of 3.6 or Days Sales Outstanding of 30.68 will help investors to properly organize and evaluate CEL SCI Corp financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

About CEL Financial Ratios Analysis

CEL SCI CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate CEL SCI investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CEL financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across CEL SCI history.

CEL SCI Financial Ratios Chart

At this time, CEL SCI's Dividend Yield is very stable compared to the past year. As of the 1st of December 2024, Inventory Turnover is likely to grow to 1.66, while PTB Ratio is likely to drop 3.60.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle

Price To Sales Ratio

Price to Sales Ratio is figured by comparing CEL SCI Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on CEL SCI sales, a figure that is much harder to manipulate than other CEL SCI Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is CEL SCI Corp dividend as a percentage of CEL SCI stock price. CEL SCI Corp dividend yield is a measure of CEL SCI stock productivity, which can be interpreted as interest rate earned on an CEL SCI investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.
Most ratios from CEL SCI's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into CEL SCI Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
At this time, CEL SCI's Dividend Yield is very stable compared to the past year. As of the 1st of December 2024, Inventory Turnover is likely to grow to 1.66, while PTB Ratio is likely to drop 3.60.
 2023 2024 (projected)
Dividend Yield0.0016870.002541
Price To Sales Ratio755.03717.28

CEL SCI fundamentals Correlations

-0.16-0.11.00.420.0-0.14-0.25-0.05-0.11.0-0.150.1-0.270.080.3-0.250.061.0-0.040.22-0.420.040.180.220.06
-0.16-0.12-0.16-0.740.13-0.72-0.35-0.08-0.12-0.15-0.720.110.09-0.820.230.22-0.25-0.160.72-0.180.14-0.67-0.25-0.26-0.3
-0.1-0.12-0.1-0.010.140.150.51-0.141.0-0.10.15-1.0-0.190.090.05-0.17-0.28-0.1-0.110.10.190.040.140.090.82
1.0-0.16-0.10.43-0.01-0.14-0.24-0.06-0.10.99-0.140.1-0.270.080.3-0.250.051.0-0.030.23-0.430.040.180.230.06
0.42-0.74-0.010.43-0.070.62-0.030.0-0.010.420.620.020.00.82-0.1-0.040.480.43-0.660.3-0.190.760.320.380.07
0.00.130.14-0.01-0.07-0.25-0.510.410.140.01-0.25-0.14-0.3-0.280.36-0.09-0.090.00.3-0.710.09-0.32-0.48-0.730.09
-0.14-0.720.15-0.140.62-0.250.320.040.15-0.141.0-0.130.370.94-0.720.280.5-0.14-0.960.210.120.910.240.310.14
-0.25-0.350.51-0.24-0.03-0.510.32-0.230.51-0.250.32-0.51-0.20.28-0.15-0.37-0.41-0.25-0.320.30.280.160.320.30.58
-0.05-0.08-0.14-0.060.00.410.04-0.23-0.14-0.060.040.14-0.28-0.01-0.12-0.240.15-0.050.04-0.650.05-0.08-0.92-0.52-0.18
-0.1-0.121.0-0.1-0.010.140.150.51-0.14-0.10.15-1.0-0.190.090.05-0.17-0.28-0.1-0.110.10.190.040.140.090.82
1.0-0.15-0.10.990.420.01-0.14-0.25-0.06-0.1-0.140.1-0.260.080.29-0.240.061.0-0.050.21-0.40.040.180.210.06
-0.15-0.720.15-0.140.62-0.251.00.320.040.15-0.14-0.140.370.94-0.720.280.5-0.14-0.960.210.120.910.240.310.14
0.10.11-1.00.10.02-0.14-0.13-0.510.14-1.00.1-0.140.19-0.08-0.050.180.290.10.1-0.09-0.19-0.03-0.14-0.08-0.82
-0.270.09-0.19-0.270.0-0.30.37-0.2-0.28-0.19-0.260.370.190.22-0.760.950.64-0.27-0.340.360.240.350.20.37-0.51
0.08-0.820.090.080.82-0.280.940.28-0.010.090.080.94-0.080.22-0.520.130.520.08-0.940.33-0.080.950.360.430.19
0.30.230.050.3-0.10.36-0.72-0.15-0.120.050.29-0.72-0.05-0.76-0.52-0.65-0.550.290.68-0.14-0.33-0.570.05-0.240.27
-0.250.22-0.17-0.25-0.04-0.090.28-0.37-0.24-0.17-0.240.280.180.950.13-0.650.69-0.24-0.240.280.190.310.140.29-0.47
0.06-0.25-0.280.050.48-0.090.5-0.410.15-0.280.060.50.290.640.52-0.550.690.06-0.480.35-0.20.60.010.45-0.38
1.0-0.16-0.11.00.430.0-0.14-0.25-0.05-0.11.0-0.140.1-0.270.080.29-0.240.06-0.040.22-0.420.050.180.220.05
-0.040.72-0.11-0.03-0.660.3-0.96-0.320.04-0.11-0.05-0.960.1-0.34-0.940.68-0.24-0.48-0.04-0.29-0.07-0.91-0.33-0.38-0.17
0.22-0.180.10.230.3-0.710.210.3-0.650.10.210.21-0.090.360.33-0.140.280.350.22-0.29-0.30.40.760.980.13
-0.420.140.19-0.43-0.190.090.120.280.050.19-0.40.12-0.190.24-0.08-0.330.19-0.2-0.42-0.07-0.3-0.07-0.21-0.31-0.18
0.04-0.670.040.040.76-0.320.910.16-0.080.040.040.91-0.030.350.95-0.570.310.60.05-0.910.4-0.070.390.490.09
0.18-0.250.140.180.32-0.480.240.32-0.920.140.180.24-0.140.20.360.050.140.010.18-0.330.76-0.210.390.670.28
0.22-0.260.090.230.38-0.730.310.3-0.520.090.210.31-0.080.370.43-0.240.290.450.22-0.380.98-0.310.490.670.11
0.06-0.30.820.060.070.090.140.58-0.180.820.060.14-0.82-0.510.190.27-0.47-0.380.05-0.170.13-0.180.090.280.11
Click cells to compare fundamentals

CEL SCI Account Relationship Matchups

CEL SCI fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio23.767.94.154.213.793.6
Book Value Per Share0.541.390.750.30.340.32
Free Cash Flow Yield(0.19)(0.0598)(0.0383)(0.0623)(0.42)(0.5)
Operating Cash Flow Per Share(0.79)(0.52)(0.42)(0.46)(0.51)(0.49)
Capex To Depreciation1.254.050.170.0940.08460.0804
Pb Ratio23.767.94.154.213.793.6
Free Cash Flow Per Share(0.53)(0.49)(0.68)(0.44)(0.52)(0.47)
Roic(1.48)(0.68)(1.11)(2.38)(2.74)(2.88)
Inventory Turnover0.02180.251.941.761.581.66
Net Income Per Share(0.88)(0.96)(0.89)(0.73)(0.65)(0.69)
Days Of Inventory On Hand16.8K1.5K188.14207.3238.39226.47
Payables Turnover0.0088180.32.41.972.262.38
Cash Per Share0.421.040.530.09320.110.1
Pocfratio(30.68)(23.79)(7.31)(2.43)(2.19)(2.3)
Interest Coverage(27.82)(31.49)(33.36)(46.6)(41.94)(44.04)
Capex To Operating Cash Flow(0.18)(0.48)(0.0362)(0.0163)(0.0187)(0.0197)
Pfcf Ratio(26.08)(16.06)(7.05)(2.39)(2.15)(2.26)
Days Payables Outstanding41.4K1.2K152.1185.32213.12202.47
Income Quality0.740.50.520.710.820.83
Roe(1.63)(0.69)(1.19)(2.45)(2.82)(2.96)
Ev To Operating Cash Flow(30.58)(22.72)(6.91)(2.85)(2.56)(2.69)
Pe Ratio(14.54)(11.4)(3.48)(1.72)(1.55)(1.62)
Return On Tangible Assets(0.9)(0.8)(0.52)(0.76)(1.07)(0.96)
Ev To Free Cash Flow(25.99)(15.34)(6.66)(2.8)(2.52)(2.65)
Earnings Yield(0.0688)(0.0877)(0.29)(0.58)(0.67)(0.64)
Intangibles To Total Assets0.0077320.0036360.00420.0064760.0074480.007075
Net Debt To E B I T D A0.05860.590.23(0.34)(0.39)(0.37)
Current Ratio3.254.1511.55.451.421.35
Tangible Book Value Per Share0.531.380.740.290.340.32

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether CEL SCI Corp is a strong investment it is important to analyze CEL SCI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CEL SCI's future performance. For an informed investment choice regarding CEL Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.52)
Revenue Per Share
0.001
Quarterly Revenue Growth
(0.63)
Return On Assets
(0.61)
Return On Equity
(2.50)
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.